IL289210A - Method for the production of an antibody - Google Patents
Method for the production of an antibodyInfo
- Publication number
- IL289210A IL289210A IL289210A IL28921021A IL289210A IL 289210 A IL289210 A IL 289210A IL 289210 A IL289210 A IL 289210A IL 28921021 A IL28921021 A IL 28921021A IL 289210 A IL289210 A IL 289210A
- Authority
- IL
- Israel
- Prior art keywords
- antibody
- producing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2820/00—Vectors comprising a special origin of replication system
- C12N2820/60—Vectors comprising a special origin of replication system from viruses
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19183171 | 2019-06-28 | ||
| PCT/EP2020/067770 WO2020260431A1 (en) | 2019-06-28 | 2020-06-25 | Method for the production of an antibody |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL289210A true IL289210A (en) | 2022-02-01 |
Family
ID=67253661
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL289210A IL289210A (en) | 2019-06-28 | 2021-12-21 | Method for the production of an antibody |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220220500A1 (https=) |
| EP (1) | EP3990484A1 (https=) |
| JP (2) | JP7511591B2 (https=) |
| KR (1) | KR102900433B1 (https=) |
| CN (1) | CN113993888B (https=) |
| AU (1) | AU2020304841B2 (https=) |
| BR (1) | BR112021025806A2 (https=) |
| CA (1) | CA3143803A1 (https=) |
| IL (1) | IL289210A (https=) |
| MX (1) | MX2021015193A (https=) |
| WO (1) | WO2020260431A1 (https=) |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| WO1988007089A1 (en) | 1987-03-18 | 1988-09-22 | Medical Research Council | Altered antibodies |
| US5010182A (en) | 1987-07-28 | 1991-04-23 | Chiron Corporation | DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides |
| AU4005289A (en) | 1988-08-25 | 1990-03-01 | Smithkline Beecham Corporation | Recombinant saccharomyces |
| US5082767A (en) | 1989-02-27 | 1992-01-21 | Hatfield G Wesley | Codon pair utilization |
| US5959177A (en) | 1989-10-27 | 1999-09-28 | The Scripps Research Institute | Transgenic plants expressing assembled secretory antibodies |
| US5795737A (en) | 1994-09-19 | 1998-08-18 | The General Hospital Corporation | High level expression of proteins |
| US6040498A (en) | 1998-08-11 | 2000-03-21 | North Caroline State University | Genetically engineered duckweed |
| CN100427603C (zh) | 1999-10-04 | 2008-10-22 | 麦迪卡格公司 | 调控外源基因转录的方法 |
| US7125978B1 (en) | 1999-10-04 | 2006-10-24 | Medicago Inc. | Promoter for regulating expression of foreign genes |
| JP2006238894A (ja) * | 2000-02-15 | 2006-09-14 | Amgen Inc | 線維芽細胞成長因子−２３分子およびその使用 |
| ATE318908T1 (de) | 2000-05-18 | 2006-03-15 | Geneart Gmbh | Synthetische gene für gagpol und deren verwendungen |
| US7879540B1 (en) | 2000-08-24 | 2011-02-01 | Promega Corporation | Synthetic nucleic acid molecule compositions and methods of preparation |
| AU2003206684A1 (en) | 2002-02-20 | 2003-09-09 | Novozymes A/S | Plant polypeptide production |
| US20040005600A1 (en) | 2002-04-01 | 2004-01-08 | Evelina Angov | Method of designing synthetic nucleic acid sequences for optimal protein expression in a host cell |
| US20060024670A1 (en) | 2004-05-18 | 2006-02-02 | Luke Catherine J | Influenza virus vaccine composition and methods of use |
| EA200700751A1 (ru) * | 2004-10-05 | 2008-06-30 | Элан Фарма Интернэшнл Лимитед | Способы и композиции для улучшения продуцирования рекомбинантного белка |
| EP2021489A2 (en) | 2006-05-30 | 2009-02-11 | Dow Global Technologies Inc. | Codon optimization method |
| DK2423315T3 (en) | 2006-06-29 | 2015-04-13 | Dsm Ip Assets Bv | A method for obtaining enhanced polypeptide expression |
| LT2167540T (lt) * | 2007-06-29 | 2018-04-25 | F. Hoffmann-La Roche Ag | Sunkioji grandinė mutantė, pagerinanti imunoglobulino gamybą |
| US7947495B2 (en) * | 2007-11-01 | 2011-05-24 | Abbott Biotherapeutics Corp. | Immunoglobulin display vectors |
| AU2009314111A1 (en) * | 2008-11-12 | 2010-05-20 | Merck Sharp & Dohme Corp. | BetaGI-IgG intron for enhanced anti-IGF1 R expression |
| US20100303776A1 (en) * | 2009-04-16 | 2010-12-02 | The University Of North Carolina At Chapel Hill | Methods and compositions for regulated expression of multiple nucleic acids |
| KR20130013435A (ko) | 2011-07-28 | 2013-02-06 | 차의과학대학교 산학협력단 | 태반-유래 줄기세포의 증식방법 |
| CN109810188A (zh) * | 2011-12-21 | 2019-05-28 | 弗·哈夫曼-拉罗切有限公司 | 用于克隆和表达关联抗体可变区基因区段的快速方法 |
| EP2794878B1 (en) * | 2011-12-22 | 2020-03-18 | F.Hoffmann-La Roche Ag | Expression vector organization, novel production cell generation methods and their use for the recombinant production of polypeptides |
| GB2502127A (en) * | 2012-05-17 | 2013-11-20 | Kymab Ltd | Multivalent antibodies and in vivo methods for their production |
| JP6224077B2 (ja) * | 2012-04-17 | 2017-11-01 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | 改変された核酸を用いてポリペプチドを発現させるための方法 |
| SG10201913396RA (en) * | 2014-02-28 | 2020-03-30 | Ichnos Sciences SA | Expression constructs and methods for selecting host cells expressing polypeptides |
| KR20180018659A (ko) * | 2015-06-08 | 2018-02-21 | 코닝 인코포레이티드 | 전달이 없는 마이크로엘이디 디스플레이 |
-
2020
- 2020-06-25 EP EP20734039.9A patent/EP3990484A1/en active Pending
- 2020-06-25 AU AU2020304841A patent/AU2020304841B2/en active Active
- 2020-06-25 KR KR1020227002552A patent/KR102900433B1/ko active Active
- 2020-06-25 JP JP2021577247A patent/JP7511591B2/ja active Active
- 2020-06-25 MX MX2021015193A patent/MX2021015193A/es unknown
- 2020-06-25 BR BR112021025806A patent/BR112021025806A2/pt unknown
- 2020-06-25 CN CN202080045482.6A patent/CN113993888B/zh active Active
- 2020-06-25 WO PCT/EP2020/067770 patent/WO2020260431A1/en not_active Ceased
- 2020-06-25 CA CA3143803A patent/CA3143803A1/en active Pending
-
2021
- 2021-12-21 IL IL289210A patent/IL289210A/en unknown
- 2021-12-22 US US17/559,934 patent/US20220220500A1/en active Pending
-
2023
- 2023-09-25 JP JP2023159322A patent/JP7835713B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3990484A1 (en) | 2022-05-04 |
| BR112021025806A2 (pt) | 2022-02-08 |
| JP7511591B2 (ja) | 2024-07-05 |
| KR102900433B1 (ko) | 2025-12-15 |
| AU2020304841B2 (en) | 2024-08-15 |
| US20220220500A1 (en) | 2022-07-14 |
| JP2023183417A (ja) | 2023-12-27 |
| CN113993888A (zh) | 2022-01-28 |
| MX2021015193A (es) | 2022-01-18 |
| JP2022538178A (ja) | 2022-08-31 |
| CA3143803A1 (en) | 2020-12-30 |
| KR20220024954A (ko) | 2022-03-03 |
| AU2020304841A1 (en) | 2021-12-23 |
| WO2020260431A1 (en) | 2020-12-30 |
| CN113993888B (zh) | 2026-01-06 |
| JP7835713B2 (ja) | 2026-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL290583A (en) | Method for the production of protein-containing foods | |
| PT3873883T (pt) | Método de síntese | |
| IL280041A (en) | Method for producing γδ t cells | |
| HUE071204T2 (hu) | Eljárás optikai hatású rétegek elõállítására | |
| PL3750866T3 (pl) | Sposób wytwarzania alkoholu z węglowodorów | |
| EP3941944A4 (en) | Claudin-6 bispecific antibodies | |
| SI3856436T1 (sl) | Način za pridobitev stroškovno ugodnih geometrično zapletenih delov | |
| IL281771A (en) | Method for selecting neoepitopes | |
| IL280651A (en) | Proteogenomic-based method for identifying tumor-specific antigens | |
| SG11202010439VA (en) | A method for optimizing antibody expression | |
| IL280064A (en) | Method of making an aerosol forming substrate | |
| EP3763743A4 (en) | BISPECIFIC ANTIBODY | |
| IL280621A (en) | Method for producing enteric neural precursors | |
| IL280323A (en) | Method for producing cd3-positive cell | |
| IL280703A (en) | Method for preparing liposomes | |
| IL286971A (en) | Method for enhancing cellular immunotherapy | |
| EP4046129C0 (fr) | Procédé de fabrication | |
| IL289252A (en) | Ep2 antagonist | |
| PT3766255T (pt) | Método para obter informações sobre uma luminária | |
| IL286684A (en) | Method for additive manufacturing an object | |
| IL280423A (en) | A method for identifying intermediates | |
| PT3612553T (pt) | Método melhorado para a produção de alto nível de crm | |
| DK3972734T3 (da) | Fremgangsmåde til katalysatorfremstilling | |
| IL285984A (en) | Method for producing influenza ha split vaccine | |
| IL288899A (en) | Method for producing dihydroisoxazole |